期刊文献+

增生性玻璃体视网膜病变中水通道蛋白-1表达的实验研究 被引量:1

Expression of aquaporin-1 in proliferative vitreoretinopathy
下载PDF
导出
摘要 目的 检测水通道蛋白-1(aquaporin-1,AQP-1)在增生性玻璃体视网膜病变(proliferative vitreoretinopathy,PVR)中的表达,以确定其在PVR细胞迁移和增殖中可能的作用。方法 从10例PVR患者的眼科手术中收集10例PVR增生膜。采用实时定量聚合酶链反应(RT-qPCR)和免疫荧光法分别确定PVR增生膜中AQP-1 mRNA和蛋白的表达。结果 RT-qPCR检测发现,AQP-1 mRNA在所有PVR增生膜中均出现了显著表达,其扩增的Cq值为27-29(28.10±0.54);免疫荧光检测发现,AQP-1标记细胞所总细胞数的比例为(25.36±2.35)%,且AQP-1蛋白主要表达在增生膜的边缘细胞中。同时10例PVR增生膜AQP-1 mRNA和蛋白质的表达非常接近,并无明显差别,与患者年龄、性别和之前是否接受过手术等无关。结论 AQP-1可能在PVR细胞迁移和增殖过程中起到了潜在的作用。 Objective To investigate the expression level of aquaporin-1(AQP4)in proliferative vitreoretinopathy(PVR),and determine the potential experimental significance of AQP-1 in diagnosis and prognosis of PVR.Methods Ten PVR membranes were surgically removed from 10 PVR patients.The real-time polymerase chain reaction(RT-PCR)methodology was used to detected the quantification of mRNA levels.In addition,immunofluorescence analysis was performed for the detection of AQP-1 protein.Results RT-qPCR results showed that AQP-1 mRNA was expressed in all PVR membranes,and the amplification quantification cycle(Cq) value was 27-29(28.10±0.54);Immunofluorescence analysis showed that AQP-1 protein was mostly expressed on the edges of the PVR membranes with the percentage of cells labeled for AQP-1 being(25.36±2.37)%.Moreover,the expression of AQP-1 mRNA and protein were not associated with age,gender,and the states whether or not accept previous surgery.Conclusion Expression of AQP-1 may play a potential role in cell migration and proliferation during the development of PVR.
出处 《眼科新进展》 CAS 北大核心 2015年第9期821-823,共3页 Recent Advances in Ophthalmology
基金 赣州市指导性科技计划项目(编号:GZ2014ZSF085)~~
关键词 增生性玻璃体视网膜病变 水通道蛋白-1 RT-QPCR 免疫荧光 proliferative vitreoretinopathy aquaporin-1 RT-qPCR immunofluores-cence
  • 相关文献

参考文献13

  • 1Innell SR, Martin GR. The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (a1lysine) by an extract from bone[J]. Proc Natl Acad Sci USA ,1968 ,61 (2) : 708-716.
  • 2Anirudh S, RobertJW , Abbot FC. Focus on molecules: Iysyl oxidase[J]. Exp Eye Res ,2012,104(2) :97-98.
  • 3王建伟,林铁柱,李世洋.增生性玻璃体视网膜病变的治疗进展[J].国际眼科杂志,2014,14(2):263-265. 被引量:4
  • 4Agre P. Aquaporin water channels[J] Biosci Rep, 2005 ,24 ( 3 ) : 127-163.
  • 5Saadoun S, Papadopoulos MC, Chikuma MH, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-I gene disruption[J]. Nature ,2005,434(7034) : 786-792.
  • 6Chikuma MH. Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing[J] .J Mol Med (Bert) ,2008,86(2) :221-231.
  • 7Meng F, Rui YF. Xu L, Wan C, Li G. AQP-I enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and beta-catenin[J]. Stem Cells Dev,2013 ,23 (I) :66-75.
  • 8Vogler S, Pannicke T, Hollborn M, Grosche A, Busch S, Hoffmann S,et at. MUlier cell reactivity in response to photoreceptor degeneration in ras with defective polycystin-2[J] . PLoS One, 2013,8(6) :61631.
  • 9Fukuda M,Nakanishi Y, Fuse M, Yokoi N ,Hamada Y, Fukagawa M , et at. Altered expression of aquaporins I and 4 coincides with neuro degenerative events in retinas of spontaneously diabetic Torti rats[J]. Exp Eye Res,2010,90( I): 17-25.
  • 10Xun W,Liu Y,Qing G,Xun X.Qing ZD,Hai WX. Aquaporin I expression in retinal neovascularization in a mouse model of retinopathy of prematurity[J] . Prep Biochem Biotechnol, 2009 , 39 (2) :208-217.

二级参考文献29

  • 1Cui J, Lei H, Samad A,et al. PDGF receptors are activated in human epiretinal membranes. Exp Eye Res 2009;88(3) :438-444 2.
  • 2Lei H, Hovland P, Velez G, et al . A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007 ;48(5 ) :2335-2342 3.
  • 3Cassidy L, Barry P, Shaw C,et al . Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 1998 ;82(2) : 181-185 4.
  • 4Connor TB Jr, Roberts AB, Sporn MB, et al . Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989;83(5) :1661-1666 5.
  • 5Kon CH, Occleston NL, Aylward GW, et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 1999 ;40(3 ) :705-712.
  • 6Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002 ;21 ( 1 ) : 127-144 7.
  • 7Hui YN, Liang HC, Cai YS, et al. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefes Arch Clin Exp Ophthalmol 1993 ;231 (2) : 109-114 8.
  • 8Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90(6) :810-816 9.
  • 9Rubsamen PE, Cousins SW. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina 1997;17(1) : 44-50 10.
  • 10Jonas JB, Hayler JK, Panda- Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000 ;84 (9) : 1064-1067 11.

共引文献3

同被引文献6

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部